Scarica l'app Stockscreener
29.72
2.43%
-0.74
Dopo l'orario di chiusura:
29.76
0.04
+0.13%
Precedente Chiudi:
$30.46
Aprire:
$30.84
Volume 24 ore:
839.71K
Relative Volume:
1.08
Capitalizzazione di mercato:
$847.68M
Reddito:
-
Utile/perdita netta:
$-69.47M
Rapporto P/E:
-5.3097
EPS:
-5.5973
Flusso di cassa netto:
$-73.92M
1 W Prestazione:
-7.04%
1M Prestazione:
-36.20%
6M Prestazione:
+4.23%
1 anno Prestazione:
+10.24%
Intervallo 1D:
$29.55
$32.00
Intervallo di 1 settimana:
$29.55
$32.92
Portata 52W:
$16.54
$50.40
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Nome
Lenz Therapeutics Inc
Settore
Industria
Telefono
858-925-7000
Indirizzo
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Confronta LENZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
29.72 | 922.05M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-14 | Ripresa | Piper Sandler | Overweight |
| 2025-03-18 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-12 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2024-04-15 | Iniziato | William Blair | Outperform |
| 2024-04-10 | Iniziato | Citigroup | Buy |
| 2024-03-27 | Iniziato | Piper Sandler | Overweight |
| 2023-02-23 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-02-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | Downgrade | Cowen | Outperform → Market Perform |
| 2023-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-01-06 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-04-14 | Iniziato | BTIG Research | Buy |
| 2022-03-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | Iniziato | Morgan Stanley | Overweight |
| 2021-07-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie
Signal strength of LENZ Therapeutics Inc. stock in tech scannersTrade Ideas & Fast Moving Market Watchlists - newser.com
What does recent volatility data suggest for LENZ Therapeutics Inc.Trade Ideas & Scalable Portfolio Growth Methods - newser.com
Will LENZ Therapeutics Inc. continue its uptrend2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Why LENZ Therapeutics Inc. stock remains on watchlistsJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Analyzing drawdowns of LENZ Therapeutics Inc. with statistical toolsJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Ranking LENZ Therapeutics Inc. among high performing stocks via toolsMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com
Is LENZ Therapeutics Inc. stock ready for a breakoutJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Real time scanner hits for LENZ Therapeutics Inc. explainedQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
Why LENZ Therapeutics Inc. stock is trending among retail tradersBull Run & Daily Stock Momentum Reports - newser.com
Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com
Will LENZ Therapeutics Inc. stock see PE expansionWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Is LENZ Therapeutics Inc. trending in predictive chart models2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
How LENZ Therapeutics Inc. stock trades before earningsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
How interest rate cuts could boost LENZ Therapeutics Inc. stockShort Setup & Smart Swing Trading Alerts - newser.com
How LENZ Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
Why LENZ Therapeutics Inc. stock remains undervaluedQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Has LENZ Therapeutics Inc. formed a bullish divergence2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com
Chart overlay techniques for tracking LENZ Therapeutics Inc.M&A Rumor & Safe Swing Trade Setups - newser.com
Combining price and volume data for LENZ Therapeutics Inc.Price Action & Verified High Yield Trade Plans - newser.com
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Lenz Therapeutics Third Quarter 2025 Financial Results and Business Update - LENZ Therapeutics
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 - The Manila Times
LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - MarketBeat
How to use a screener to detect LENZ Therapeutics Inc. breakouts2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Why LENZ Therapeutics Inc. stock is considered a top pickJuly 2025 Retail & Weekly High Return Forecasts - fcp.pa.gov.br
Published on: 2025-10-28 06:22:08 - newser.com
Lenz Therapeutics Inc Azioni (LENZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):